Corvus Pharmaceuticals (CRVS) Net Income Growth (3y) (2018 - 2026)
Corvus Pharmaceuticals (CRVS) Net Income Growth (3y) (2018 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 65,719.23 Bn | 65,718.94 Bn | - | 9.16% |
| 2 | Nanobiotix | 1,933.82 Bn | 1,933.76 Bn | - | - |
| 3 | Akari Therapeutics | 959.56 Bn | 959.56 Bn | - | - |
| 4 | BeOne Medicines | 470.97 Bn | 466.18 Bn | 1.35 Bn | 38.43% |
| 5 | Vertex Pharmaceuticals | 122.29 Bn | 115.05 Bn | 2.59 Bn | 13.80% |
| 6 | Regeneron Pharmaceuticals | 69.98 Bn | 61.22 Bn | 3.31 Bn | -3.84% |
| 7 | Belite Bio | 62.06 Bn | 62.06 Bn | - | - |
| 8 | Argenx Se | 55.78 Bn | 50.60 Bn | 1.41 Bn | 79.26% |
| 9 | Alnylam Pharmaceuticals | 37.43 Bn | 34.42 Bn | 959.66 Mn | 47.10% |
| 10 | Corvus Pharmaceuticals | 1.19 Bn | 952.14 Mn | - | -28.70% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -28.70% |
| Sep 30, 2025 | 8.13% |
| Jun 30, 2025 | -1.18% |
| Mar 31, 2025 | 58.84% |
| Sep 30, 2024 | -61.01% |
| Jun 30, 2024 | 31.97% |
| Mar 31, 2024 | 20.67% |
| Dec 31, 2023 | 17.62% |
| Sep 30, 2023 | 20.38% |
| Jun 30, 2023 | 21.98% |
| Mar 31, 2023 | 22.73% |
| Dec 31, 2022 | 20.30% |
| Sep 30, 2022 | -3.71% |
| Jun 30, 2022 | 18.05% |
| Mar 31, 2022 | 13.25% |
| Dec 31, 2021 | 11.91% |
| Sep 30, 2021 | 6.64% |
| Jun 30, 2021 | 0.76% |
| Mar 31, 2021 | 6.73% |
| Dec 31, 2020 | 32.82% |